Journal Management System
ScopeMed is an
Online Journal/Article Management system
that can enable all of the operations of
the editorial functions of a journal.
Home  |   Add your Journal  |   Properties of ScopeMed  |   Video Tutorials  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  

Psikiyatride Güncel Yaklaşımlar
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry
Periodical of Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry
Journal Home Page
ISSN: 1309-0658 (Print)
ISSN: 1309-0674 (Online)
Language: [ Turkish ]   [ English ]  

  » Volume 5, Issue 2
      pp. 127-259
  » Volume 5, Issue 1
      pp. 1-126

 

Open Access

Review Article



Impulsivity and Its Treatment

Pınar Güzel Özdemir, Yavuz Selvi, Adem Aydın.

A B S T R A C TR E F E R E N C E S 

Abstract
Identification, description and therapeutic management of impulsivity, which underlies the mechanism and coexistence of many neurological and psychiatric diseases, are considered to be very crucial. Treatment can be applied in two ways; either for the disorder that occurs with impulsivity or for the treatment of the impulsive behavior itself. Disorders associated with or accompanied by impulsivity can be classified as borderline and antisocial personality disorders, schizophrenia, bipolar disorder, attention deficit and hyperactivity disorder, eating disorders, substance use disorders. In addition, impulsivity can manifest itself within the context of diagnostic criteria implicated in the impulse control disorders which include pathological gambling, intermittent explosive disorder, pyromania, kleptomania and trichotillomania. Behavioral and pharmacological interventions that are effective in treatment plans for these disorders should be integrated. These can be listed as insight-oriented psychotherapy and cognitive-behavioral psychotherapies, contingency management, and pharmacotherapy. The aim of the current review is to understand impulsivity and discuss its relation to other psychiatric disorders and to focus on the treatment of impulsivity.

Key words: Impulsivity, treatment, psychiatric disorder



Dürtüsellik ve Tedavisi

Özet
BBirçok nörolojik ve psikiyatrik hastalığın temelinde yer alan ya da beraberinde seyreden dürtüselliğin tanımlanması ve tedavisinin düzenlenmesi oldukça önemlidir. Tedavide ya dürtüsellik ile ortaya çıkan hastalığın tedavisi ya da dürtüsel davranışın kendisinin tedavi edilmesi şeklinde iki yola başvurulabilir. Dürtüselliğin eşlik ettiği bozukluklar arasında antisosyal ve borderline kişilik bozuklukları, şizofreni, bipolar bozukluk, dikkat eksikliği hiperaktivite bozukluğu, yeme bozuklukları, madde kullanım bozuklukları sayılabilir. Ayrıca dürtü kontrol bozuklukları olan patolojik kumar oynama, aralıklı patlayıcı bozukluk, piromani, kleptomani ve trikotillomani tanı ölçütleri içerisinde bir ölçüt olarak bulunur. Bu bozuklukların tedavi planında etkin olan davranışsal ve farmakolojik müdahalelerin bütünleştirilmesi gerekir. Bunlar içgörü yönelimli ve bilişsel-davranışçı psikoterapiler, beklenmedik olayların yönetimi ve farmakoterapi olarak sıralanabilir. Bu yazıda, dürtüselliğin tanımı, diğer psikiyatrik bozukluklarla birlikteliği ve tedavisi aktarılmıştır.

Anahtar Kelimeler: Dürtüsellik, tedavi, psikiyatrik bozukluk


ARTICLE TOOLS
Abstract
PDF Fulltext
Email this Article
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Pınar Güzel Özdemir
Articles by Yavuz Selvi
Articles by Adem Aydın
on IndexScholar Fulltext
on Google
on Google Scholar
Article Statistics
 Viewed: 482
Downloaded: 142
(Last 7 Days: 5)
Cited: 0
Emailed: 0

REFERENCES
1. Yazıcı K, Yazıcı AE. Dürtüselliğin nöroanatomik ve nörokimyasal temelleri. Psikiyatride Güncel Yaklaşımlar 2010; 2:254-280.

2. Hollander E, Evers M. New developments in impulsivity. Lancet 2001; 358(9286):949-950.
[
DOI via Crossref]   

3. Eysenck SB, Eysenck HJ. The place of impulsiveness in a dimensional system of personality description. Br J Soc Clin Psychol 1977; 16:57-68.
[
DOI via Crossref]    [Pubmed]   

4. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 1995; 51:768-774.
[
DOI via Crossref]   

5. Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull 1975; 82:463-498.
[
DOI via Crossref]    [Pubmed]   

6. L’Abate L. A family theory of impulsivity. In The Impulsive Client (Eds WG McCown, JL Johnson, MB Shure):93-117. Washington DC, American Psychological Association, 1993.
[
DOI via Crossref]   

7. Moeller G, Barratt E, Dougherty D, Schmitz M, Swann A. Psychiatric aspects of impulsivity. Am J Psychiatry 2001; 158:1783-1793.
[
DOI via Crossref]    [Pubmed]   

8. Rachlin H. The Science of Self Control. Cambridge, Mass, Harvard University Press, 2000.

9. Hollander E, Stein D. Clinical Manual of Impulse-control Disorders. Arlington, American Psychiatric Publishing, 2005.

10. Hollander E, Rosen J. Impulsivity. J Psychopharmacol 2000; 4(suppl 1):39-44.

11. Barratt ES, Stanford MS, Kent TA, Felthous A. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol Psychiatry 1997; 41:1045-1061.
[
DOI via Crossref]   

12. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989; 46:587-599.
[
DOI via Crossref]    [Pubmed]   

13. Blair RJ, Cipolotti L. Impaired social response reversal: a case of “acquired sociopathy”. Brain 2000; 123:1122-1141.
[
DOI via Crossref]    [Pubmed]   

14. Bechara A, Damasio H, Tranel D, Damasio AR. Deciding advantageously before knowing the advantageous strategy. Science 1997; 275:1293-1295.
[
DOI via Crossref]    [Pubmed]   

15. Links PS, Heslegrave R, van Reekum R. Impulsivity: core aspect of borderline personality disorder. J Pers Disord 1999; 13:1-9.
[
DOI via Crossref]    [Pubmed]   

16. Soloff PH, Lis JA, Kelly T, Cornelius J, Ulrich R. Risk factors for suicidal behavior in borderline personality disorder. Am J Psychiatry 1994; 151:1316-1323.
[
Pubmed]   

17. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999; 156:181-189.
[
Pubmed]   

18. Swann AC, Janicak PL, Calabrese JR, Bowden CL, Dilsaver SC, Morris DD et al. Structure of mania: subgroups with distinct clinical characteristics and course of illness in randomized clinical trial participants. J Affect Disord 2001; 67:123-132.
[
DOI via Crossref]   

19. Güleç H, Tamam L, Usta H, Saygılı İ, Güleç MY, Zengin M et al. Bipolar bozuklukta dürtüsellik. Anadolu Psikiyatri Dergisi 2009; 10:198-203.

20. Swann AC, Koslow SH, Katz MM, Maas JW, Javaid J, Secunda SK, et al. Lithium carbonate treatment of mania: cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry 1987; 44:345-354.
[
DOI via Crossref]    [Pubmed]   

21. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999; 146:373-390.
[
DOI via Crossref]    [Pubmed]   

22. Brady KT, Myrick H, McElroy S. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict 1998; 7:221-230.
[
Pubmed]   

23. Willcutt EG, Pennington BF, Chhabildas NA, Friedman MC, Alexander J. Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins. J Am Acad Child Adolesc Psychiatry 1999; 38:1355-1362.
[
DOI via Crossref]   

24. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del’Homme MA et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 1998; 3:427-430.
[
DOI via Crossref]    [Pubmed]   

25. Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, Lim KO. DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport 2004; 15:2467-2470.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

26. Enticott PG, Ogloff JRP, Bradshaw JL, Fitzgerald PB. Cognitive inhibitory control and self reported imulsivity among violent offendes with schizophrenia. J Clin Exp Neuropsychol 2008; 30:157-162.
[
DOI via Crossref]    [Pubmed]   

27. Kısa C, Yıldırım SG, Göka E. Ataklık ve ruhsal bozukluklar. Turk Psikiyatri Derg 2005; 16:46-54.
[
Pubmed]   

28. Fahy T, Eisler I. Impulsivity and eating disorders. Br J Psychiatry 1993; 162:193-197.
[
DOI via Crossref]    [Pubmed]   

29. Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P, et al. Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 2001; 31:85-95.
[
DOI via Crossref]    [Pubmed]   

30. Fenichel O. The Psychoanalytic Theory of Neurosis. New York, WW Norton, 1945.

31. Aronson TA. A critical review of psychotherapeutic treatments of borderline personality. J Nerv Ment Dis 1989; 177:511-528.
[
DOI via Crossref]    [Pubmed]   

32. Platt JJ, Taube DO, Metzger D, Duome MAJ. Training in interpersonal problem solving (TIPS). J Cogn Psychother 1988; 2:5-34.

33. Linehan MM: Dialectical behavioral therapy in groups: treating borderline personality disorders and suicidal behavior. In Women’s Therapy Groups: Paradigms of Feminist Treatment (Ed CM Brody):145-162. New York, Springer, 1987.

34. Baer RA, Nietzel MT. Cognitive and behavioral treatment of impulsivity in children: a meta-analytic review of the outcome literature. J Clin Child Psychol 1991; 20:400-412.
[
DOI via Crossref]   

35. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantrona RL. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol 2000; 68:64-72.
[
DOI via Crossref]    [Pubmed]   

36. Pelham WE, Carlson C, Sams SE, Vallano G, Dixon MJ, Hoza B. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit hyperactivity disorder in the classroom. J Consult Clin Psychol 1993; 61:506-515.
[
DOI via Crossref]    [Pubmed]   

37. Sheard MH. Effect of lithium in human aggression. Nature 1971; 230:113-114.
[
DOI via Crossref]    [Pubmed]   

38. Goodwin FK, Fireman B, Simon GE, Hunkelel EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290:1467-1473.
[
DOI via Crossref]    [Pubmed]   

39. Bierbrauer J, Nilsson A, Müller-Oerlinghausen B, Bauer M. Therapeutic and prophylatic effects of lithium on pathological aggression. In Lithium in Neuropsychiatry (Eds M Bauer, P Grog, B Müller-Oerlinghausen):227-236. Abingdon, Informa, 2006.

40. Olvera RL. Intermitant expolsive disorder: epidemiology, diagnosis and management. CNS Drugs 2002; 16:517-526.
[
DOI via Crossref]    [Pubmed]   

41. Citrome L, Casey DE, Daniel DG, Wozniak P, Kochan LD, Tracy KA. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. Psychiatr Serv 2004; 55:290-294.
[
DOI via Crossref]    [Pubmed]   

42. Gobbi G, Gaudreau PO, Leblanc N. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis. J Clin Psychopharmacol 2006; 26:467-473.
[
DOI via Crossref]    [Pubmed]   

43. Hollander E, Tracy KA, Swann AC, Coccaro EF, McElroy SL, Wozniak P et al. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 2003; 28:1186-1197.
[
Pubmed]   

44. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 2005; 162:621-624.
[
DOI via Crossref]    [Pubmed]   

45. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988; 45:111-119.
[
DOI via Crossref]    [Pubmed]   

46. Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998; 155:54-61.
[
Pubmed]   

47. Stanford MS, Helfritz LE, Conklin SM, Villemarette-Pittman NR, Grve KW, Adams D et al. A comparison of anticonvulsants in the treatment of impulsive aggression. Exp Clin Psychopharmacol 2005; 13:72-77.
[
DOI via Crossref]    [Pubmed]   

48. Mattes JA. Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo controlled trial. J Clin Psychopharmacol 2005; 25:575-579.
[
DOI via Crossref]    [Pubmed]   

49. Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK et al. Topiramate treatment of aggression in female borderline personality disorder: a double blind, placebo-controlled study. J Clin Psychiatry 2004; 65:1515-1519.
[
DOI via Crossref]    [Pubmed]   

50. Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K et al. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry 2005; 57:495-499.
[
DOI via Crossref]    [Pubmed]   

51. do Prado-Lima PA, Kristensen CH, Bacaltchuck J. Can childhood trauma predict response to topiramate in borderline personality disorder? J Clin Pharm Ther 2006; 31:193-196.
[
DOI via Crossref]    [Pubmed]   

52. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC et al. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 1998; 155:373-379.
[
Pubmed]   

53. Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2006; 63:622-629.
[
DOI via Crossref]    [Pubmed]   

54. Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, McEvoy J et al. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatr Serv 2001; 52:1510-1514.
[
DOI via Crossref]    [Pubmed]   

55. Volavka J, Czobor P, Nolan K, Sheitman B, Lindenmayer JP, Citrome L et al. Overt aggression on psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol 2004; 24:225-228.
[
DOI via Crossref]    [Pubmed]   

56. Swanson JW, Swartz MS, Elbogen EB, Van Dorn RA. Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. J Clin Psychiatry 2004; 65:1666-1673.
[
DOI via Crossref]    [Pubmed]   

57. Schulz SC, Camlin KL, Berry SA, Jesberger JA, Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 1999; 46:1429-1435.
[
DOI via Crossref]   

58. Soler J, Pascual JC, Campins J, Barrachina J, Puigdemont D, Alvarez E et al. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry 2005; 162:1221-1224.
[
DOI via Crossref]    [Pubmed]   

59. Connor DF, McLaughlin TJ, Jeffers-Terry M. Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder. J Child Adolesc Psychopharmacol 2008; 18:140-156.
[
DOI via Crossref]   

60. Greendyke RM, Kanter DR, Schuster DB, Verstreate S, Wootton J. Propanolol treatment of assaultive patients with organic brain disease: a double-blind crossover, placebo controlled study. J Nerv Ment Dis 1986; 174:290-294.
[
DOI via Crossref]    [Pubmed]   

61. Greendyke RM, Kanter DR. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry 1986; 47:423-426.
[
Pubmed]   

62. Pappadopulos E, Woolston S, Chait A, Perkins M, Connor DF, Jensen PS. Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. J Can Acad Child Adolesc Psychiatry 2006; 15:27-39.
[
Pubmed]    [PMC Free Fulltext]   

63. Petry NM. Pathological Gambling: Etiology, Comorbidities, and Treatment. Washington D.C., American Psychological Association, 2005.
[
DOI via Crossref]   

64. Reist C, Nakamura K, Sagart E, Sokolski KN, Fujimoto KA. Impulsive aggressive behavior: open-label treatment with citalopram. J ClinPsychiatry 2003, 64:81-85.
[
DOI via Crossref]    [Pubmed]   

65. Tamam L. Piromani (Patolojik Yangın Çıkarma). Turkiye Klinikleri J Psychiatry-Special Topics 2009; 2(1):20-28.

66. Swedo SE, Leonard HL, Rapopart JL. A double-blind comparison of clomipramine and desimipramine in the treatment of tricotillomania. N Eng J Med 1989; 321:497-501.
[
DOI via Crossref]    [Pubmed]   

67. Christenson GA, Pophin MK, Machenzie TB, Realmuto GM. Lithium treatment of chronic hair pulling. J Clin Psychiatry 1991; 52:116-120.
[
Pubmed]   

68. De Sousa A. An open-label pilot study of naltrexone in childhood trichotillomania. J Child Adolesc Psychopharmacol 2008; 18:30-33.
[
DOI via Crossref]    [Pubmed]   

69. McElroy SL, Pope HG, Jr. Hudson JI, Keck PE, Jr. White KL. Kleptomania: a report of 20 cases. Am J Psychiatry 1991; 148:652-657.
[
Pubmed]   

70. Kim SW. Opioid antagonists in the treatment of impulse control disorders. J Clin Psychiatry 1998; 59:159-164.
[
DOI via Crossref]   

71. Tamam L. Dürtü kontrol bozukluklarında ilaç tedavisi. In Temel Psikofarmakoloji, 1. Baskı (Ed N Yüksel) :1089-1099. Ankara, Türkiye Psikiyatri Derneği, 2010.

72. Annagür BB, Tamam L. Depresyon hastalarında dürtü kontrol bozuklukları eş tanıları. Nöropsikiyatri Arşivi 2011; 48:22-30.

73. Güleç H. Ayaktan başvuruda bulunan alkol kötüye kullanan erkek hastalarda impulsivite: bir ön çalışma. Yeni Symposium 2010; 48:102-109.

74. Selvi Y, Aydin A, Atli A, Boysan M, Selvi F, Besiroglu L. Chronotype differences in suicidal behavior and impulsivity among suicide attempters. Chronobiol Int 2011; 28:170-175.
[
DOI via Crossref]    [Pubmed]   


How to Cite this Article
Pubmed Style

Özdemir PG, Selvi Y, Aydın A. [Impulsivity and Its Treatment]. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. 2012; 4(3): 293-314. Turkish. doi:10.5455/cap.20120418



Web Style

Özdemir PG, Selvi Y, Aydın A. [Impulsivity and Its Treatment]. www.scopemed.org/?mno=13223 [Access: May 22, 2013]. Turkish. doi:10.5455/cap.20120418



AMA (American Medical Association) Style

Özdemir PG, Selvi Y, Aydın A. [Impulsivity and Its Treatment]. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. 2012; 4(3): 293-314. Turkish. doi:10.5455/cap.20120418



Vancouver/ICMJE Style

Özdemir PG, Selvi Y, Aydın A. [Impulsivity and Its Treatment]. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. (2012), [cited May 22, 2013]; 4(3): 293-314. Turkish. doi:10.5455/cap.20120418



Harvard Style

Özdemir, P. G., Selvi, Y. & Aydın, A. (2012) [Impulsivity and Its Treatment]. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry, 4 (3), 293-314. Turkish. doi:10.5455/cap.20120418



Turabian Style

Özdemir, Pınar Güzel, Yavuz Selvi, and Adem Aydın. 2012. [Impulsivity and Its Treatment]. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry, 4 (3), 293-314. Turkish. doi:10.5455/cap.20120418



Chicago Style

Özdemir, Pınar Güzel, Yavuz Selvi, and Adem Aydın. "[Impulsivity and Its Treatment]." Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 4 (2012), 293-314. Turkish. doi:10.5455/cap.20120418



MLA (The Modern Language Association) Style

Özdemir, Pınar Güzel, Yavuz Selvi, and Adem Aydın. "[Impulsivity and Its Treatment]." Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 4.3 (2012), 293-314. Print.Turkish. doi:10.5455/cap.20120418



APA (American Psychological Association) Style

Özdemir, P. G., Selvi, Y. & Aydın, A. (2012) [Impulsivity and Its Treatment]. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry, 4 (3), 293-314. Turkish. doi:10.5455/cap.20120418




» Last Downloads

Please Wait...




Total Download: 29.851
(for Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry)
Total Submission during last 24 hours: 156


» For Authors




Become Reviewer


» Login Area




Follow ScopeMed on Twitter

ScopeMed Home | About ScopeMed | Contact Us | Terms & Conditions | Privacy Policy
The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of SAGE Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.